Clinical Trials Sponsored by Protara Therapeutics

Total 6345 results

Protara Therapeutics

Recruiting

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age (STARBORN-1)

Lymphatic Malformation

United States
Protara Therapeutics

Completed

Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition (THRIVE-1)

Intestinal Failure-associated Liver Disease

United States, Denmark, United Kingdom, Italy
Protara Therapeutics

Recruiting

Dose Expansion, Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer (ADVANCED-2)

Non-muscle Invasive Bladder Cancer

United States, Ukraine
Protara Therapeutics

Recruiting

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer (Phase 1a) (ADVANCED-1)

Non-muscle Invasive Bladder Cancer

United States, Moldova, Republic of, Romania, Ukraine
Protara Therapeutics

Recruiting

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer (ADVANCED-1)

Non-muscle Invasive Bladder Cancer

United States
Prothya Biosolutions

Active, not recruiting

Apotransferrin in Atransferrinemia

Congenital Atransferrinemia

Spain, Germany, Italy
Prothya Biosolutions

Terminated

Apotransferrin in Patients With β-thalassemia

β-thalassemia Intermedia

Netherlands
Mortara Instrument

Unknown

Non-Invasive Blood Pressure Monitor Accuracy in Neonatal Subjects

Non-invasive Blood Pressure

Italy
Mortara Instrument

Completed

Accuracy of Pulse Oximeters With Profound Hypoxia

Oximetry, Pulse

United States
Prothya Biosolutions

Completed

Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery

CPB | Oral Anticoagulant Therapy

Belgium
Prothya Biosolutions

Completed

Pharmacokinetics of New HepBQuin

Healthy

Germany
Prothya Biosolutions

Completed

Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml (Nanogam)

Primary Immunodeficiency

Netherlands
Prothya Biosolutions

Completed

Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response (Subklasse)

Infections | IgG Deficiency

Netherlands
Prothya Biosolutions

Completed

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

Angioedema

Netherlands
Prothya Biosolutions

Completed

Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients

Hypogammaglobulinemia

Netherlands
Prothya Biosolutions

Completed

Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy

Myocardial Diseases | Parvovirus B19, Human

Netherlands
Prothya Biosolutions

Completed

C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema

Angioedema

Netherlands
Prothya Biosolutions

Completed

Kinetics, Efficacy and Safety of C1-Esteraseremmer-N

Hereditary Angioedema Type I | Angioneurotic Edema

Netherlands
ProThera, Inc.

Unknown

Efficacy of Myalgesin™ to Support Joint Function in Patients With Knee Osteoarthritis

Osteoarthritis

United States
Prothya Biosolutions

Completed

Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)

Hemophilia B

Netherlands
Prothya Biosolutions

Completed

Efficacy and Safety of IVIG-L in ITP Patients

Purpura, Thrombocytopenic, Idiopathic

Poland
ProArc Medical

Recruiting

Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH (Omega)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Georgia
ProArc Medical

Recruiting

Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Israel
Patara Pharma

Completed

Treatment of Refractory Chronic Cough With PA101

Refractory Chronic Cough

Netherlands, United Kingdom
ProArc Medical

Completed

Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia

Benign ProstaticHyperplasia (BPH)

Israel, Latvia
Patara Pharma

Completed

Treatment of Uremic Pruritus With PA101B

Uremic Pruritus

United States
Patara Pharma

Completed

Treatment of Indolent Systemic Mastocytosis With PA101

Systemic Mastocytosis | Mastocytosis | Indolent Systemic Mastocytosis

France, Germany, Spain, Italy, Netherlands
Procare Riaya Hospital

Completed

The Cricoid Pressure in Pediatric Patients

Aspiration Pneumonia | Cricoid Cartilage | Pediatric

Saudi Arabia
Proclara Biosciences, Inc.

Terminated

Multiple Ascending Dose Study in Healthy Subjects

Amyloidosis

Netherlands
Medical Procare PLLC

Completed

Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients

Chronic Hepatitis B

United States
Procare Riaya Hospital

Unknown

Minimum Alveolar Concentrations of Sevoflurane for Maintaining Bispectral Index Below 50 in Morbidly Obese Patients

Anesthesia

Saudi Arabia
Protina Pharmazeutische GmbH

Completed

Magnesium Supplementation in Type II Diabetes

Effect of Magnesium in Diabetes

Germany
Proclara Biosciences, Inc.

Completed

A Study of NPT189 in Healthy Subjects

Amyloidosis

Netherlands
Procare Riaya Hospital

Completed

Comparison Between 3 Solutions of Bupivacaine of Adductor Canal Block for Anterior Cruciate Ligament Reconstruction

Postoperative Pain

Saudi Arabia
Procare Riaya Hospital

Unknown

Does the Position of the Esophageal Entrance Determine the Cricoid Force Necessary to Occlude the Esophageal Lumen (CP)

Aspiration

Saudi Arabia
Procare Riaya Hospital

Unknown

Does Pre-operative Patients' Education Facilitates Emergence of Anesthesia Following Bariatric Surgery?

Obesity

Saudi Arabia
Procare Riaya Hospital

Completed

Efficacy of Cricoid Pressure in Occluding the Esophageal Entrance: A Glidescope ® Study (CP)

Aspiration

Saudi Arabia
Procare Riaya Hospital

Unknown

The Cricoid Force Necessary to Occlude the Esophageal Entrance: Is There a Gender Difference?

ASPIRATION

Saudi Arabia
Procare Riaya Hospital

Completed

The Median Effective Dose (ED50) of Paracetamol and Morphine : A Study of Interaction Study

Postoperative Pain

Saudi Arabia
Procare Health Iberia S.L.

Completed

Evaluate Clinical Benefit of Local Treatment With KD Intra-Articular® Gel in Patients With Osteoarthritis (NO-DOLOR2) (NO-DOLOR2)

Osteoarthritis, Hip | Osteoarthritis Thumb | Osteoarthritis Ankle

Spain
Procare Health Iberia S.L.

Completed

Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy (IDRA)

Vulvovaginal Atrophy

Spain
Procare Health Iberia S.L.

Completed

Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV (PAPILOCAN)

HPV Infection | Lesion Cervix

Spain
Procare Health Iberia S.L.

Completed

Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction. (LIBIDOBS)

Female Sexual Dysfunction

Spain
Procare Health Iberia S.L.

Withdrawn

Study to Evaluate the Effectiveness and Safety of Libicare® in Women With Low Arousal and Sexual Desire Levels (VITAL)

Female Sexual Interest/Arousal Disorder

Spain
UMC Utrecht
Prothya Biosolutions

Terminated

Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture (CAESAR)

Sepsis | Inflammation | Trauma | Multiple Organ Dysfunction Syndrome

Netherlands
Erasmus Medical Center
Prothya Biosolutions

Unknown

Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS (HS-COST)

Hidradenitis Suppurativa

Netherlands
Prothya Biosolutions
PRA Health Sciences

Completed

Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation

Healthy Volunteers

Netherlands
Erasmus Medical Center
Prothya Biosolutions

Terminated

Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) (ConCoVid-19)

COVID-19

Netherlands
Proclara Biosciences, Inc.
Alzheimer's Association

Completed

Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease

Alzheimer Disease

United States
Protina Pharmazeutische GmbH
Comenius University

Completed

Magnesium Supplementation in Stress Conditions

Stress Physiology

Slovakia

3

Subscribe